News
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...
A tomato recall due to risk of salmonella contamination has been designated as Class I, the U.S. Food and Drug Administration ...
11h
News Medical on MSNClairity BREAST receives FDA authorization for AI-based breast cancer risk predictionClairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, ...
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...
In alignment with the FDA’s aim to phase out petroleum-based dyes, the agency has approved three color additives from natural ...
12don MSNOpinion
It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
- The FDA grants Priority Review designation for the evaluation of medicines that, if approved, would provide a significant ...
The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...
Its new guidance would trade the clarity and reach of our current strategy for a confusing framework that simply doesn’t fit reality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results